Entourage Health Corp.
$0.00+$0.00 (+14.29%)
Entourage Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 72.97% below the high.
OTC · DIGP · USD
Stock price, earnings
Quote as of Aug 12, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Digipath, Inc.’s quoted price sits in the lower half of its reported 52-week range, 85.14% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Digipath, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Digipath, Inc., with its subsidiaries, offers essential laboratory testing for cannabis and hemp, primarily serving Nevada's licensed medical marijuana enterprises from its base in Las Vegas. Beyond these core analytical services, the company also provides comprehensive support to the broader cannabis industry, including educational programs, professional training, and news coverage. As a dedicated testing laboratory, Digipath analyzes various products such as cannabis, cannabis-infused items, hemp, and other botanical nutraceuticals, catering to cultivators, dispensaries, caregivers, producers, patients, and end-users of these botanical goods. A critical aspect of their operations involves rigorously screening medicinal and recreational cannabis for potential contaminants. This includes checks for residual solvents, moisture content, water activity, and visual integrity, alongside identifying pesticides, a spectrum of heavy metals (like mercury, arsenic, lead, cadmium, chromium, and nickel), biological toxins (including aflatoxin and ocratoxins), and a wide array of microbial contaminants (such as E. coli, salmonella, coliforms, aspergillus, gram-negative bacteria, total aerobic bacteria, mold, and yeast). Digipath, Inc. was established in 2010 and is headquartered in Las Vegas, Nevada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:18 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00+$0.00 (+14.29%)
Entourage Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 72.97% below the high.
$0.16$0.00 (0.0%)
RegenETP, Inc.’s quoted price sits in the upper half of its reported 52-week range, 27.93% below the high.
$0.01+$0.01 (+316.67%)
Novation Companies, Inc.: Healthcare · Medical - Care Facilities.
$0.37+$0.04 (+12.12%)
InVivo Therapeutics Holdings Corporation’s quoted price sits in the lower half of its reported 52-week range, 73.76% below the high.
$0.00$0.00 (0.0%)
Nutroganics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Suvanza Pharma, LLC’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01-$0.00 (-12.9%)
Pure Extracts Technologies Corp.’s quoted price sits in the lower half of its reported 52-week range, 12.9% below the high.
$0.00$0.00 (0.0%)
American Caresource Holdings, Inc.: Healthcare · Medical - Care Facilities.